Multi-view deep learning based molecule design and structural optimization accelerates the SARS-CoV-2 inhibitor discovery

• URL: http://arxiv.org/abs/2212.01575v1
• Date: Sat, 3 Dec 2022 08:21:13 GMT
• Title: Multi-view deep learning based molecule design and structural optimization accelerates the SARS-CoV-2 inhibitor discovery
• Authors: Chao Pang, Yu Wang, Yi Jiang, Ruheng Wang, Ran Su, and Leyi Wei
• Abstract summary: We propose MEDICO, a Multi-viEw Deep generative model for molecule generation, structural optimization, and SARS-CoV-2 Inhibitor disCOvery. We show that our MEDICO significantly outperforms the state-of-the-art methods in generating valid, unique, and novel molecules under benchmarking comparisons. Case study results on targeted molecule generation for the SARS-CoV-2 main protease (Mpro) show that by integrating molecule docking into our model as chemical priori, we successfully generate new small molecules with desired drug-like properties for the Mpro, potentially accelerating the de novo design of Covid
• Score: 10.974317147338303
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: In this work, we propose MEDICO, a Multi-viEw Deep generative model for molecule generation, structural optimization, and the SARS-CoV-2 Inhibitor disCOvery. To the best of our knowledge, MEDICO is the first-of-this-kind graph generative model that can generate molecular graphs similar to the structure of targeted molecules, with a multi-view representation learning framework to sufficiently and adaptively learn comprehensive structural semantics from targeted molecular topology and geometry. We show that our MEDICO significantly outperforms the state-of-the-art methods in generating valid, unique, and novel molecules under benchmarking comparisons. In particular, we showcase the multi-view deep learning model enables us to generate not only the molecules structurally similar to the targeted molecules but also the molecules with desired chemical properties, demonstrating the strong capability of our model in exploring the chemical space deeply. Moreover, case study results on targeted molecule generation for the SARS-CoV-2 main protease (Mpro) show that by integrating molecule docking into our model as chemical priori, we successfully generate new small molecules with desired drug-like properties for the Mpro, potentially accelerating the de novo design of Covid-19 drugs. Further, we apply MEDICO to the structural optimization of three well-known Mpro inhibitors (N3, 11a, and GC376) and achieve ~88% improvement in their binding affinity to Mpro, demonstrating the application value of our model for the development of therapeutics for SARS-CoV-2 infection.

Related papers

• FARM: Functional Group-Aware Representations for Small Molecules [55.281754551202326]
  We introduce Functional Group-Aware Representations for Small Molecules (FARM) FARM is a foundation model designed to bridge the gap between SMILES, natural language, and molecular graphs. We rigorously evaluate FARM on the MoleculeNet dataset, where it achieves state-of-the-art performance on 10 out of 12 tasks.
  arXiv  Detail & Related papers  (2024-10-02T23:04:58Z)
• Medication Recommendation via Dual Molecular Modalities and Multi-Step Enhancement [6.927266015351967]
  Existing works based on molecular knowledge neglect the 3D geometric structure of molecules and fail to learn the high-dimensional information of medications. We propose a bimodal molecular recommendation framework named BiMoRec, which introduces 3D molecular structures to obtain atomic 3D coordinates and edge indices.
  arXiv  Detail & Related papers  (2024-05-30T07:13:08Z)
• Learning Over Molecular Conformer Ensembles: Datasets and Benchmarks [44.934084652800976]
  We introduce the first MoleculAR Conformer Ensemble Learning benchmark to thoroughly evaluate the potential of learning on conformer ensembles. Our findings reveal that direct learning from an conformer space can improve performance on a variety of tasks and models.
  arXiv  Detail & Related papers  (2023-09-29T20:06:46Z)
• An Equivariant Generative Framework for Molecular Graph-Structure Co-Design [54.92529253182004]
  We present MolCode, a machine learning-based generative framework for underlineMolecular graph-structure underlineCo-design. In MolCode, 3D geometric information empowers the molecular 2D graph generation, which in turn helps guide the prediction of molecular 3D structure. Our investigation reveals that the 2D topology and 3D geometry contain intrinsically complementary information in molecule design.
  arXiv  Detail & Related papers  (2023-04-12T13:34:22Z)
• A Molecular Multimodal Foundation Model Associating Molecule Graphs with Natural Language [63.60376252491507]
  We propose a molecular multimodal foundation model which is pretrained from molecular graphs and their semantically related textual data. We believe that our model would have a broad impact on AI-empowered fields across disciplines such as biology, chemistry, materials, environment, and medicine.
  arXiv  Detail & Related papers  (2022-09-12T00:56:57Z)
• Retrieval-based Controllable Molecule Generation [63.44583084888342]
  We propose a new retrieval-based framework for controllable molecule generation. We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria. Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
  arXiv  Detail & Related papers  (2022-08-23T17:01:16Z)
• Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model [4.815696666006742]
  Structure-based de novo method can overcome the data scarcity of active by incorporating drug-target interaction into deep generative architectures. Here, we demonstrate a widely used and fast protein sequence-based reinforcement learning model for drug discovery. As a proof of concept, the RL model was utilized to design molecules for four targets.
  arXiv  Detail & Related papers  (2022-08-14T10:41:52Z)
• Benchmarking Deep Graph Generative Models for Optimizing New Drug Molecules for COVID-19 [11.853524110656991]
  Design of new drug compounds with target properties is a key area of research in generative modeling. We present a small drug molecule design pipeline based on graph-generative models and a comparison study of two state-of-the-art graph generative models for designing COVID-19 targeted drug candidates.
  arXiv  Detail & Related papers  (2021-02-09T17:49:26Z)
• CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models [74.58583689523999]
  We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins. CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme. CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
  arXiv  Detail & Related papers  (2020-04-02T18:17:20Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.